drs. H.D. Hoving

E-mail:
h.d.hoving umcg.nl

Research

Publications
  1. Early F-18-FDHT PET/CT as a predictor of treatment response in mCRPC treated with enzalutamide.

    Hoving, H., Palthe, S., Vallinga, M., Dost, R., Gietema, J. A., Antunes, I., De Vries, E. F. J., Glaudemans, A. & de Jong, I. J., 1-Mar-2019, In : Journal of Clinical Oncology. 37, 7_Suppl, p. 232-232 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  2. EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study

    Campos, A. K., Hoving, H. D., Rosati, S., van Leenders, G. J. L. H. & de Jong, I. J., 29-Sep-2016, In : International Journal of Molecular Sciences. 17, 10, 9 p., 1650.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy

    Rybalov, M., Ananias, H. J. K., Hoving, H. D., van der Poel, H. G., Rosati, S. & de Jong, I. J., 10-Apr-2014, In : International Journal of Molecular Sciences. 15, 4, p. 6046-6061 16 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model

    Domanska, U. M., Boer, J. C., Timmer-Bosscha, H., van Vugt, M. A. T. M., Hoving, H. D., Kliphuis, N. M., Rosati, S., van der Poel, H. G., de Jong, I. J., de Vries, E. G. E. & Walenkamp, A. M. E., Oct-2014, In : Clinical & experimental metastasis. 31, 7, p. 829-839 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (8) »

View graph of relations

ID: 416697